Skip to content
AIMarketCap

Abridge

PrivateRank #40 by valueUnited StatesFounded 2018abridge.com

Healthcare AI company building a clinician intelligence platform that turns patient-clinician conversations and health-record context into documentation, decision support, coding and workflow actions.

AI valuation
$5.3B*92.7%increase
Jun 23, 2025 · Becker's Hospital Review
Change vs Feb 17, 2025

Key stats

Funding recorded · 4 rounds
$1.02B†
Revenue
—
Releases · last 12 months
9
Upcoming
—
Models
1
Platforms & products
4
Latest release
Oct 6, 2026
Most active in
Corporate
Employees
—
Open roles · Oct 6, 2026
32 open roles
Users · Jun 11, 2026
300 health systems

Recent releases

View all →
Oct 6, 2026Abridge open roles snapshot32 open roles†

A third-party tracker listed 32 currently open roles at Abridge.

Sep 22, 2026Abridge selected for VA ambient AI enterprise contract

The U.S. Department of Veterans Affairs selected Abridge to provide ambient AI under an enterprise contract.

Abridge PartnershipAbridge
Aug 17, 2026Abridge extends context-aware intelligence to every clinician at partner systemsAbridge Clinical Decision Support

Abridge enabled partner health systems to extend its clinical intelligence agent to clinicians regardless of how they document visits.

Jun 11, 2026Abridge reaches 300 health systems and 100M annual conversations300 health systems

Abridge reported that it was live at more than 300 health systems and expected to support over 100 million patient-clinician conversations annually.

Abridge User countAbridge
Jun 11, 2026Abridge and NVIDIA announce clinical-conversation foundation modelAnnouncedClinical Conversations Foundation Model

Abridge and NVIDIA announced development of a foundation model purpose-built for clinical conversations using NVIDIA Nemotron and Blackwell infrastructure.

Jun 11, 2026Abridge introduces Clinical Decision SupportAbridge Clinical Decision Support · Abridge Clinical Decision Support

Abridge introduced context-aware clinical decision support that brings cited medical evidence into the EHR using the patient record and ongoing conversation.

Jun 11, 2026Abridge unveils patient-centered clinician intelligence platformAbridge Clinician Intelligence Platform · Clinician Intelligence Platform

Abridge unveiled an AI-native platform connecting care delivery, payment and evidence-based treatment around each patient encounter.

Apr 15, 2026Abridge partners with NEJM and JAMA

Abridge partnered with the New England Journal of Medicine and JAMA to integrate peer-reviewed evidence shaped by clinical conversations into clinician workflows.

Abridge PartnershipAbridge

Upcoming

Calendar →

Nothing scheduled.

AI valuation history

3 events
Financials →
$0
$2.5B
$5B
$7.5B
$10B
2025
Abridge AI valuation: Feb 22, 2024 $850M; Feb 17, 2025 $2.75B; Jun 23, 2025 $5.3B

Models

1
ModelReleased

Platforms & products

4
Sources 15
  • Oct 6, 2026 · Abridge open roles snapshotJob Opportunities API
  • Sep 22, 2026 · Abridge selected for VA ambient AI enterprise contractAbridge
  • Aug 17, 2026 · Abridge extends context-aware intelligence to every clinician at partner systemsAbridge
  • Jun 11, 2026 · Abridge reaches 300 health systems and 100M annual conversationsAbridge
  • Jun 11, 2026 · Abridge and NVIDIA announce clinical-conversation foundation modelAbridge
  • Jun 11, 2026 · Abridge introduces Clinical Decision SupportAbridge
  • Jun 11, 2026 · Abridge unveils patient-centered clinician intelligence platformAbridge
  • Apr 15, 2026 · Abridge partners with NEJM and JAMAAbridge
  • Apr 1, 2026 · Abridge raises $316M Series E extensionSacra
  • Jun 23, 2025 · Abridge expands to more than 150 enterprise health systemsAbridge
  • Jun 23, 2025 · Abridge raises $300M Series EAbridge
  • Feb 17, 2025 · Abridge surpasses 100 health-system deploymentsAbridge
  • Feb 17, 2025 · Abridge launches Contextual Reasoning EngineAbridge
  • Feb 17, 2025 · Abridge raises $250M Series DAbridge
  • Feb 22, 2024 · Abridge raises $150M Series CAbridge

* Market cap / valuation. Company values are AI-attributed: the latest market cap or valuation × the share attributed to AI (100% for pure AI companies). Methodology